Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Orthovita highlights benefits of Cortoss bone material

Orthovita highlights benefits of Cortoss bone material

20th July 2010

Orthovita is to present data at a medical conference this week which illustrates the potential benefits of Cortoss, its bone augmentation material.

Dr Hyun Bae, of The Spine Institute at Saint John’s Health Center in Santa Monica, will present results from the new Cortoss clinical study at the International Meeting of the Advanced Spine Technologies in Canada.

The trial was conducted among 256 vertebral compression fracture patients and compared Cortoss to a polymethylmethacrylate control substance, finding that Orthovita’s product delivered better levels of pain relief.

In addition, Cortoss was shown to be superior in terms of helping patients to either maintain or recover their physical functions and avoid disability in the long term.

Dr Bae, who acted as clinical investigator in this trial, said: “The combined results of these studies show the effectiveness of vertebroplasty and that Cortoss has substantial clinical benefits as a vertebroplasty material.”

According to Orthovita’s most recent financial report in May 2010, the company has seen a strong start to the year so far, with first quarter sales exceeding those of the corresponding period of 2009 by 11 per cent.

We currently have 7 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.